The {pharmaceutical industry is currently exploring innovative treatment strategies for obesity , and the arrival of semaglutide 10mg injectables represents the advancement . Clinicians are beginning to assess the possible benefits and risks associated with this higher potency product, especially in comparison to existing lower-dose semaglutide pro